GlassScriptPhysician profile
Barry J Weinberg
NPI 1063431666
$6,746.04
in general payments reported to CMS, 2019-2025
14 companies · $2,836 in 2025
The $2,836 reported for 2025 was more than what 82% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,230 · 2020: $16.84 · 2021: $11.11 · 2022: $161 · 2023: $461 · 2024: $1,030 · 2025: $2,836.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,235 · Education: $92.13.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,234.60 |
| Education | $92.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $2,891.71 | 2019-2025 | Jardiance, Ofev, Spiriva Respimat |
| Astrazeneca Pharmaceuticals LP | $1,671.09 | 2024-2025 | Airsupra, Breztri, Tezspire |
| Glaxosmithkline, LLC. | $848.08 | 2022-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Insmed, INC. | $507.70 | 2023-2025 | Arikayce, Brinsupri |
| Verona Pharma, INC. | $175.82 | 2025 | Ohtuvayre |
| Xeris Pharmaceuticals, INC. | $150.00 | 2025 | Recorlev |
| Amgen INC. | $139.89 | 2024-2025 | Tezspire |
| Mallinckrodt Hospital Products INC. | $110.12 | 2025 | Acthar |
| Electromed, INC. | $87.21 | 2024-2025 | Smartvest |
| Optinose US, INC. | $64.07 | 2024-2025 | |
| Azurity Pharmaceuticals, INC. | $31.97 | 2025 | Alvesco |
| Teva Pharmaceuticals USA, INC. | $27.95 | 2020-2021 | |
| Baxter Healthcare | $24.00 | 2022 | |
| Inspire Medical Systems, INC. | $16.43 | 2025 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Weinberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.